Neurological & CognitiveResearch OnlyB

DSIP

Delta Sleep-Inducing Peptide

Delta sleep-inducing peptide (DSIP) is a nonapeptide first isolated in 1977 from thalamic perfusate of sleeping rabbits by Monnier et al. that induced slow-wave (delta) sleep when infused. Subsequent research has explored roles in pain modulation, stress response, temperature regulation, and antioxidant effects. Clinical evidence is limited and inconsistent; mechanism remains poorly characterized. Research only.

XRedditFacebook
Observational report only — live community data. Not medical advice. Does not recommend doses, protocols, or treatments.
Studies cited
6
Research grade
B
Experience
56

Overall check-ins

Activity
62

Trackers & reports

Overview

About DSIP

Delta sleep-inducing peptide (DSIP) is a nonapeptide first isolated in 1977 from thalamic perfusate of sleeping rabbits by Monnier et al. that induced slow-wave (delta) sleep when infused. Subsequent research has explored roles in pain modulation, stress response, temperature regulation, and antioxidant effects. Clinical evidence is limited and inconsistent; mechanism remains poorly characterized. Research only.

Category
Neurological & Cognitive
Regulatory status
Research Only
Also known as
Delta Sleep-Inducing Peptide
Self-reports
50

Community

What 50 users report

50 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 3% · Mixed 97% · Unfavorable overall 0%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Sleep
183
Mood
182

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Headache
177

Self-reported dose per injection

Median bucket: 200–400 mcg · Most common: 200–400 mcg

Reports span 25–600 mcg

25–50
5
50–100
2
100–200
38
200–400
132
400–600
6

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

How repeat users are trending

Among repeat reporters, 85% said they felt similar to their last entry, 15% more positive, and 0% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 62 days · Based on 33 repeat reporters

Research

Cited research (5)

Tools

Explore more

Explore

More ways to learn about DSIP from observational PeptIQ data.

Compare with

Related peptides

Help

Frequently asked

What do PeptIQ users report about DSIP?

This page summarizes 50 anonymized self-reports from PeptIQ users who track DSIP, including commonly reported effects and co-tracked peptides. These are observational patterns, not clinical outcomes.

How do side effects relate to overall experience for DSIP?

PeptIQ separates overall check-in ratings (favorable, mixed, or unfavorable) from logged side effects like nausea or fatigue. Users often report benefits and side effects in the same check-in — a high experience score does not mean zero side effects were noted.

What research is cited for DSIP?

5 sources are linked on this page, including PubMed articles, clinical trial registries, and FDA labels where applicable. Citations describe published research — not recommendations.

Is DSIP safe to use?

This wiki does not assess safety or recommend use. DSIP is listed as Research Only. Consult a licensed clinician for personal medical decisions.

What are the purported benefits and uses of DSIP?

This wiki summarizes observational community reports and linked citations for DSIP. It does not assert therapeutic benefits. See the cited research list on this page and the educational profile for DSIP for study-level context — not medical advice.

What is the legal status of DSIP?

DSIP is listed in PeptIQ as Research Only. Regulatory status varies by jurisdiction and can change. This wiki does not provide legal advice; check current FDA and local rules and talk with a licensed clinician or counsel for personal decisions.

What are the known or theoretical side effects and risks of DSIP?

Safety data quality for DSIP varies widely by compound and study design. PeptIQ does not establish a risk profile here. Review primary literature, product labeling where applicable, and clinician guidance. Community self-reports are not a substitute for clinical evidence.

What is the current state of research on DSIP?

This page links 5 indexed sources for DSIP. Evidence maturity differs by application — some peptides have large human programs, others are mostly preclinical. Treat citation counts as literature volume, not proof of efficacy.